Nano-X Imaging Faces Class Action Over Alleged Misleading Disclosures

The litigation centers on claims that Nano-X failed to provide accurate information regarding the efficiency of its Korean chip manufacturing facility and its overall demand trajectory during a November 2025 registered direct offering. According to the complaint, the company raised $15 million while allegedly concealing that operating expenses were unsustainable and that a significant restructuring of its manufacturing operations was imminent.

The lawsuit asserts that these omissions violated the Securities Exchange Act of 1934 and SEC Rule 10b-5. The discrepancy came to light on April 20, 2026, when corrective disclosures revealed a $17.5 million impairment charge, triggering a sharp decline in the company's share price. Plaintiffs argue that management maintained an artificially inflated stock price by touting operational progress while fully aware of the misalignment between production capacity and actual market demand.

Investors who incurred losses during the class period have until August 11, 2026, to file motions for lead plaintiff. Levi & Korsinsky, LLP is currently evaluating claims for those who acquired shares in the November 2025 offering or throughout the broader class period, noting that participation in such litigation is typically handled on a contingency basis.